We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
-15.12%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$425M
AUM Growth
+$61.1M
Cap. Flow
+$123M
Cap. Flow %
28.85%
Top 10 Hldgs %
10.46%
Holding
597
New
218
Increased
138
Reduced
75
Closed
166

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.26M
2
MCHP icon
Microchip Technology
MCHP
+$4.22M
3
HCA icon
HCA Healthcare
HCA
+$4M
4
GD icon
General Dynamics
GD
+$3.93M
5
ICE icon
Intercontinental Exchange
ICE
+$3.92M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$4.83M
2
ABT icon
Abbott
ABT
+$4.13M
3
COP icon
ConocoPhillips
COP
+$3.73M
4
CI icon
Cigna
CI
+$3.43M
5
QCOM icon
Qualcomm
QCOM
+$3.42M

Sector Composition

Rank Sector Weight
1 Technology 16.73%
2 Healthcare 15.22%
3 Consumer Discretionary 14.22%
4 Financials 13.03%
5 Industrials 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
1
Lowe's Companies
LOW
$113B
$5.4M 1.27%
30,905
+10,906
+55% +$2.1M
HD icon
2
Home Depot
HD
$324B
$4.86M 1.14%
17,712
+1,544
+10% +$456K
MA icon
3
Mastercard
MA
$464B
$4.55M 1.07%
14,435
+1,923
+15% +$662K
NKE icon
4
Nike
NKE
$61.6B
$4.49M 1.06%
43,940
+15,057
+52% +$1.78M
PFE icon
5
Pfizer
PFE
$142B
$4.42M 1.04%
84,317
+63,040
+296% +$3.21M
PEP icon
6
PepsiCo
PEP
$183B
$4.32M 1.02%
25,930
+19,474
+302% +$3.28M
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.3M 1.01%
53,897
+24,380
+83% +$2.31M
ABBV icon
8
AbbVie
ABBV
$450B
$4.27M 1%
+27,896
New +$4.26M
PPG icon
9
PPG Industries
PPG
$25.5B
$4.03M 0.95%
35,199
+14,861
+73% +$1.86M
ADBE icon
10
Adobe
ADBE
$86.7B
$3.86M 0.91%
10,542
+730
+7% +$297K
GD icon
11
General Dynamics
GD
$104B
$3.78M 0.89%
+17,095
New +$3.93M
FTV icon
12
Fortive
FTV
$18.6B
$3.77M 0.89%
92,099
+61,325
+199% +$2.71M
MCHP icon
13
Microchip Technology
MCHP
$44.9B
$3.7M 0.87%
+63,764
New +$4.22M
HCA icon
14
HCA Healthcare
HCA
$82.9B
$3.63M 0.85%
21,592
+18,613
+625% +$4M
BAC icon
15
Bank of America
BAC
$428B
$3.57M 0.84%
114,747
+101,795
+786% +$3.67M
PG icon
16
Procter & Gamble
PG
$341B
$3.57M 0.84%
+24,829
New +$3.73M
AVTR icon
17
Avantor
AVTR
$7.69B
$3.48M 0.82%
111,848
+20,953
+23% +$654K
LIN icon
18
Linde
LIN
$235B
$3.47M 0.82%
+12,060
New +$3.77M
ICE icon
19
Intercontinental Exchange
ICE
$80.9B
$3.45M 0.81%
+36,715
New +$3.92M
SCHW
20
Charles Schwab
SCHW
$177B
$3.41M 0.8%
53,979
+24,358
+82% +$1.68M
PSX icon
21
Phillips 66
PSX
$85.7B
$3.29M 0.77%
40,088
+29,006
+262% +$2.68M
WY icon
22
Weyerhaeuser
WY
$17B
$3.27M 0.77%
98,716
+37,694
+62% +$1.44M
CVS icon
23
CVS Health
CVS
$136B
$3.27M 0.77%
35,257
+16,946
+93% +$1.65M
REGN icon
24
Regeneron Pharmaceuticals
REGN
$67.1B
$3.17M 0.74%
+5,358
New +$3.48M
GIS icon
25
General Mills
GIS
$19.3B
$3.14M 0.74%
41,620
+38,592
+1,275% +$2.7M
1
2 3 4 5

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Pearl River Capital held 597 positions worth $425M, up 17% from $364M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Pearl River Capital deployed $123M of net new capital in Q2 2022, opening 218 new positions and adding to 138 existing holdings. Its largest new stake was AbbVie: 27,896 shares worth $4.27M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Cigna, an estimated $3.43M trimmed.

  • Pearl River Capital's largest Q2 2022 buy was AbbVie: 27,896 shares worth $4.27M.
  • Pearl River Capital added most to HCA Healthcare in Q2 2022, an estimated $4M increase.
  • Pearl River Capital's biggest Q2 2022 reduction was Cigna, cutting an estimated $3.43M.
  • Pearl River Capital fully exited Chevron in Q2 2022, selling an estimated $4.83M.
  • Pearl River Capital's ten largest holdings make up 10% of its $425M portfolio in Q2 2022.
  • Pearl River Capital opened 218 new positions and closed 166 in Q2 2022.
  • Pearl River Capital's portfolio value rose 17% quarter-over-quarter to $425M.

Based on Pearl River Capital's 13F filing for Q2 2022, filed 12 Aug 2022.